AIRLINK 69.92 Increased By ▲ 4.72 (7.24%)
BOP 5.46 Decreased By ▼ -0.11 (-1.97%)
CNERGY 4.50 Decreased By ▼ -0.06 (-1.32%)
DFML 25.71 Increased By ▲ 1.19 (4.85%)
DGKC 69.85 Decreased By ▼ -0.11 (-0.16%)
FCCL 20.02 Decreased By ▼ -0.28 (-1.38%)
FFBL 30.69 Increased By ▲ 1.58 (5.43%)
FFL 9.75 Decreased By ▼ -0.08 (-0.81%)
GGL 10.12 Increased By ▲ 0.11 (1.1%)
HBL 114.90 Increased By ▲ 0.65 (0.57%)
HUBC 132.10 Increased By ▲ 3.00 (2.32%)
HUMNL 6.73 Increased By ▲ 0.02 (0.3%)
KEL 4.44 No Change ▼ 0.00 (0%)
KOSM 4.93 Increased By ▲ 0.04 (0.82%)
MLCF 36.45 Decreased By ▼ -0.55 (-1.49%)
OGDC 133.90 Increased By ▲ 1.60 (1.21%)
PAEL 22.50 Decreased By ▼ -0.04 (-0.18%)
PIAA 25.39 Decreased By ▼ -0.50 (-1.93%)
PIBTL 6.61 Increased By ▲ 0.01 (0.15%)
PPL 113.20 Increased By ▲ 0.35 (0.31%)
PRL 30.12 Increased By ▲ 0.71 (2.41%)
PTC 14.70 Decreased By ▼ -0.54 (-3.54%)
SEARL 57.55 Increased By ▲ 0.52 (0.91%)
SNGP 66.60 Increased By ▲ 0.15 (0.23%)
SSGC 10.99 Increased By ▲ 0.01 (0.09%)
TELE 8.77 Decreased By ▼ -0.03 (-0.34%)
TPLP 11.51 Decreased By ▼ -0.19 (-1.62%)
TRG 68.61 Decreased By ▼ -0.01 (-0.01%)
UNITY 23.47 Increased By ▲ 0.07 (0.3%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
BR100 7,399 Increased By 104.2 (1.43%)
BR30 24,136 Increased By 282 (1.18%)
KSE100 70,910 Increased By 619.8 (0.88%)
KSE30 23,377 Increased By 205.6 (0.89%)

Wall Street’s main indexes were set for a higher open on Tuesday as Treasury yields fell in the run-up to the Federal Reserve’s monetary policy meeting, while investors assessed the latest batch of earnings reports.

The three main indexes rallied more than 1% in the previous session, rebounding from a selloff in the past few weeks that was sparked by surging Treasury yields and the Middle East conflict.

U.S. equities are tracking their third straight month in the red, with the S&P 500 and the Nasdaq on course for their worst October since 2018.

On the earnings front, heavy machinery maker Caterpillar fell nearly 5% in premarket trading as the company’s dealer inventories rose and a large order backlog shrunk, indicating that equipment demand is starting to slow.

Pfizer’s shares edged 0.7% lower after the drugmaker reported its first quarterly loss since 2019.

Helping broader markets, the yield on the ten-year U.S. Treasury note slid to 4.82%, a day after the Treasury Department said it expects to borrow $76 billion less this quarter than previously anticipated.

Wall St eyes higher open as investors await Fed rate verdict, more earnings

“The earnings this morning look mixed. But the 10-year dropping a little bit is an encouragement for the market,” said Kim Forrest, chief investment officer at Bokeh Capital Partners.

The quarterly earnings season has crossed the halfway mark, with 77.7% of the 251 companies in the S&P 500 that have reported earnings so far surpassing analysts’ estimates, according to LSEG data.

The Fed kicks off a two-day monetary policy meeting on Tuesday at the end of which it is widely expected to hold interest rates steady, according to the CME Group’s FedWatch tool.

Commentary at the end of the meeting on Wednesday would be crucial in assessing how long monetary policy could stay restrictive amid recent signs of economic strength.

Along with earnings, a slew of labor market data throughout the week will also be in focus, culminating in Friday’s non-farm payrolls report, for further clues on the strength of the U.S. economy.

The Bank of Japan tweaked its bond yield control policy again on Tuesday, further loosening its grip on long-term interest rates.

At 8:26 a.m. ET, Dow e-minis were up 59 points, or 0.18%, S&P 500 e-minis were up 13.5 points, or 0.32%, and Nasdaq 100 e-minis were up 35.75 points, or 0.25%.

Pinterest jumped 16% premarket as the image sharing platform beat third-quarter revenue and profit estimates on a stabilizing digital advertising market.

U.S.-listed shares of Chinese companies such as JD.Com, Alibaba, PDD Holdings and Bilibili shed between 1.1% and 2.1% after data showed China’s manufacturing activity unexpectedly contracted in October.

VF Corp dropped 6.1% after the Vans sneaker-maker withdrew its annual forecast, while cloud solutions provider Arista Networks gained 10.3% on an upbeat fourth-quarter revenue outlook.

Sarepta Therapeutics slumped 40.9% as the drug developer’s muscle disorder gene therapy failed in a late-stage trial. Shares of Sarepta’s client Catalent also fell 11.8%.

Comments

200 characters